Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update.
Barbara L AndersenChristina LacchettiKimlin Tan AshingJonathan S BerekBarry S BermanSage BolteDon S DizonBarbara A GivenLarissa NekhlyudovWilliam F PirlAnnette L StantonJulia H RowlandPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
It is recommended to use a stepped-care model, that is, provide the most effective and least resource-intensive intervention based on symptom severity. All oncology patients should be offered education regarding depression and anxiety. For patients with moderate symptoms of depression, clinicians should offer cognitive behavior therapy (CBT), behavioral activation (BA), MBSR, structured physical activity, or empirically supported psychosocial interventions. For patients with moderate symptoms of anxiety, clinicians should offer CBT, BA, structured physical activity, acceptance and commitment therapy, or psychosocial interventions. For patients with severe symptoms of depression or anxiety, clinicians should offer cognitive therapy, BA, CBT, MBSR, or interpersonal therapy. Treating clinicians may offer a pharmacologic regimen for depression or anxiety for patients who do not have access to first-line treatment, prefer pharmacotherapy, have previously responded well to pharmacotherapy, or have not improved following first-line psychological or behavioral management.Additional information is available at www.asco.org/survivorship-guidelines.
Keyphrases
- sleep quality
- physical activity
- palliative care
- depressive symptoms
- healthcare
- mental health
- end stage renal disease
- clinical trial
- body mass index
- randomized controlled trial
- stem cells
- newly diagnosed
- quality improvement
- papillary thyroid
- study protocol
- social media
- bone marrow
- chronic pain
- patient reported outcomes
- health insurance
- prognostic factors